S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Vivos Therapeutics, Inc. Common Stock

VVOS XNAS
$1.15 -0.08 (-6.78%) ▼ 15-min delayed
Open
$1.17
High
$1.18
Low
$1.12
Volume
111.2K
Market Cap
$12.35M

About Vivos Therapeutics, Inc. Common Stock

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 109 Website →

Key Financials

Period Revenue Net Income EPS
Q3 2025 $6.78M $-5,400,000 $-0.49
Q2 2025 $3.82M $-5,013,000 $-0.55
Q1 2025 $3.02M $-3,864,000 $-0.45
FY 2024 $15.03M $-11,136,000 $-2.22

Earnings & Analyst Ratings

Next Earnings: Wed, May 13, 2026
Calendar →

Related Market News

No specific coverage for VVOS yet. Check out our latest market news or earnings calendar.

Get VVOS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Vivos Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.